Follow the Genpharmasec share price and the full insider trade history of the company, a listed issuer based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €625.7m. The latest transaction was disclosed on 1 September 2026 (Acquisition). Among the most active insiders: Rajesh Sadhwani. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Genpharmasec is a company specializing in the pharmaceutical sector, providing innovative solutions for drug safety. It is listed on the XBOM.